Concepedia

Selvan Pillay

SP

Statistics

Publications

5

Citations

85

H-Index

5

Active since

2021

Affiliations

Emory University(Current)

University of KwaZulu-Natal

Harvard University

University of Rochester

National Health Laboratory Service

Selvan Pillay is an author at Emory University specializing in antiviral resistance, molecular virology, and antiviral drug resistance.

ORCID

Publications per year

2021–2023

5

Publications

5

Resistance Testing for Management of HIV Virologic Failure in Sub-Saharan Africa

Mark J. Siedner, Mahomed‐Yunus S. Moosa, Suzanne M. McCluskey et al. · Annals of Internal Medicine · 2021 · 23 citations · Full text

, , +17

Point-of-care urine tenofovir testing to predict HIV drug resistance among individuals with virologic failure

Suzanne M. McCluskey, Katya Govender, John Adamson et al. · AIDS · 2023 · 20 citations · Full text

, , +16

Impact of pre-existing drug resistance on risk of virological failure in South Africa

Jonathan Z. Li, Natalia Stella-Ascariz, Manish C. Choudhary et al. · Journal of Antimicrobial Chemotherapy · 2021 · 19 citations · Full text

, , +17

Tenofovir diphosphate levels in dried blood spots are associated with virologic failure and resistance to first‐line therapy in South Africa: a case–control cohort study

José Castillo‐Mancilla, Johnathan A. Edwards, Jaysingh Brijkumar et al. · Journal of the International AIDS Society · 2021 · 13 citations · Full text

, , +15

Who’s slipping through the cracks? A comprehensive individual, clinical and health system characterization of people with virological failure on first‐line HIV treatment in Uganda and South Africa

Zahra Reynolds, Suzanne M. McCluskey, Mahomed Yunus Suleman Moosa et al. · HIV Medicine · 2021 · 10 citations · Full text

, , +16

1–5 of 5